Producing more medicines responsibly and sustainably: the Baclair example
At the Baclair site in Normandy, the Servier Group is strengthening its global production capacity for Daflon® while working to minimize its environmental footprint.
Hover and click the numbers in the image to discover more!
1
2
3
4
1
A new synthesis pathway for the active pharmaceutical ingredient of Daflon® has been developed. It is characterized by a reduced environmental impact, notably through the use of alternative, biodegradable solvents such as methanol.
2
The methanol used is recovered and then converted into methane. This gas is subsequently reinjected into the system to supply the site’s boilers, with the objective of making the installation energy self-sufficient.
3
A wastewater treatment plant has been built to manage aqueous discharges.
4
The construction of the new GF3 unit is part of a broader dynamic of local industrial development.
Over five years, 100 jobs will be created in the region.
By producing locally, the site also helps secure the supply of medicines and strengthen France’s health sovereignty.
Over five years, 100 jobs will be created in the region.
By producing locally, the site also helps secure the supply of medicines and strengthen France’s health sovereignty.
1
A new synthesis pathway for the active pharmaceutical ingredient of Daflon® has been developed. It is characterized by a reduced environmental impact, notably through the use of alternative, biodegradable solvents such as methanol.
2
The methanol used is recovered and then converted into methane. This gas is subsequently reinjected into the system to supply the site’s boilers, with the objective of making the installation energy self-sufficient.
3
A wastewater treatment plant has been built to manage aqueous discharges.
4
The construction of the new GF3 unit is part of a broader dynamic of local industrial development.
Over five years, 100 jobs will be created in the region.
By producing locally, the site also helps secure the supply of medicines and strengthen France’s health sovereignty.
Over five years, 100 jobs will be created in the region.
By producing locally, the site also helps secure the supply of medicines and strengthen France’s health sovereignty.
Making a significant social impact
As a company committed to health care, we naturally feel a responsibility to care for the world in which we live. We aim to strengthen the social impact we have among patients, employees, partners and the communities in which we operate, while constantly striving to minimize our environmental footprint.